Guidelines for Parkinson's disease treatment consensus from the Movement Disorders Scientific Department of the Brazilian Academy of Neurology- motor symptoms

Imagem de Miniatura
Arquivos
art_SABA_Guidelines_for_Parkinsons_disease_treatment_consensus_from_the_2022.PDF (205.08 KB)
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2022
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC ARQUIVOS NEURO- PSIQUIATRIA
Autores
SABA, Roberta Arb
MAIA, Debora Palma
CARDOSO, Francisco Eduardo Costa
BORGES, Vanderci
ANDRADE, Luiz Augusto F.
FERRAZ, Henrique Ballalai
RIEDER, Carlos Roberto de Mello
SILVA, Delson Jose da
Citação
ARQUIVOS DE NEURO-PSIQUIATRIA, v.80, n.3, p.316-329, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The treatment of Parkinson's disease (PD) is challenging, especially since it is considered highly individualized. The Brazilian Academy of Neurology has recognized the need to disseminate knowledge about the management of PD treatment, adapting the best evidence to the Brazilian reality. Thus, the main published treatment guidelines were reviewed based on the recommendations of group from the Movement Disorders Scientific Department of the Brazilian Academy of Neurology.
O tratamento da doença de Parkinson (DP) constitui um desafio, especialmente por ser considerado muito individualizado. A Academia Brasileira de Neurologia (ABN) identificou a necessidade de disseminar o conhecimento sobre o manejo do tratamento da DP, adaptando as melhores evidências à realidade brasileira. Assim, foi realizada uma revisão sobre as principais orientações de tratamento publicadas, baseada nas recomendações elaboradas por um grupo de especialistas em transtornos do movimento do departamento científico da ABN.
Palavras-chave
Parkinson Disease, Antiparkinson Agents, Deep Brain Stimulation, Rehabilitation, Doença de Parkinson, Antiparkinsonianos, Estimulação Encefálica Profunda, Reabilitação
URI
https://observatorio.fm.usp.br/handle/OPI/47360
Referências
  1. Andersohn F, 2009, MOVEMENT DISORD, V24, P129, DOI 10.1002/mds.22385
  2. [Anonymous], 1997, JAMA, V278, P125
  3. [Anonymous], 2002, Mov Disord, V17 Suppl 4, pS7
  4. Atkinson-Clement C, 2015, NEURODEGENER DIS MAN, V5, P233, DOI [10.2217/nmt.15.16, 10.2217/NMT.15.16]
  5. Barichella M, 2006, MOVEMENT DISORD, V21, P1682, DOI 10.1002/mds.21003
  6. Biglan KM, 2009, ARCH NEUROL-CHICAGO, V66, P563, DOI 10.1001/archneur.66.1.nct90001
  7. Borgohain R, 2014, MOVEMENT DISORD, V29, P229, DOI 10.1002/mds.25751
  8. Cabreira V, 2019, DRUGS, V79, P593, DOI 10.1007/s40265-019-01098-w
  9. Canning CG, 2015, NEUROLOGY, V84, P304, DOI 10.1212/WNL.0000000000001155
  10. Capato TTC, 2020, PHYS THER, V100, P2023, DOI 10.1093/ptj/pzaa146
  11. Capato TTC, 2020, J NEUROL SCI, V418, DOI 10.1016/j.jns.2020.117086
  12. Ory-Magne F, 2014, NEUROLOGY, V82, P300, DOI 10.1212/WNL.0000000000000050
  13. Pahwa R, 2006, NEUROLOGY, V66, P983, DOI 10.1212/01.wnl.0000215250.82576.87
  14. PAHWA R, 1993, NEUROLOGY, V43, P677, DOI 10.1212/WNL.43.4.677
  15. Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223
  16. Parkinson Study Group, 2000, JAMA, V284, P1931
  17. Perry EK, 2003, ANN NEUROL, V54, P235, DOI 10.1002/ana.10639
  18. Poewe WH, 2007, LANCET NEUROL, V6, P513, DOI 10.1016/S1474-4422(07)70108-4
  19. Pollak Pierre, 2013, Handb Clin Neurol, V116, P97, DOI 10.1016/B978-0-444-53497-2.00009-7
  20. Rao AK, 2010, MOVEMENT DISORD, V25, pS146, DOI 10.1002/mds.22784
  21. Rascol O, 2005, LANCET, V365, P947, DOI 10.1016/S0140-6736(05)71083-7
  22. Rochester L, 2010, BRAIN RES, V1319, P103, DOI 10.1016/j.brainres.2010.01.001
  23. Rodrigues FB, 2017, EXPERT OPIN PHARMACO, V18, P445, DOI 10.1080/14656566.2017.1294683
  24. Rossi M, 2018, MOV DISORD CLIN PRAC, V5, P246, DOI 10.1002/mdc3.12592
  25. Rughani A, 2018, NEUROSURGERY, V82, P753, DOI 10.1093/neuros/nyy037
  26. Schapira AHV, 2013, EUR J NEUROL, V20, P271, DOI 10.1111/j.1468-1331.2012.03840.x
  27. Schenkman M, 2018, JAMA NEUROL, V75, P219, DOI 10.1001/jamaneurol.2017.3517
  28. Schwid SR, 2005, ARCH NEUROL-CHICAGO, V62, P241
  29. Serratrice Jacques, 2002, Cardiol Rev, V10, P334, DOI 10.1097/00045415-200211000-00005
  30. Shannon KM, 1997, NEUROLOGY, V49, P724, DOI 10.1212/WNL.49.3.724
  31. SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305
  32. Siderowf A, 2002, ARCH NEUROL-CHICAGO, V59, P1937
  33. Stocchi F, 2008, MOVEMENT DISORD, V23, pS599, DOI 10.1002/mds.22052
  34. Stocchi F, 2012, MOVEMENT DISORD, V27, P106, DOI 10.1002/mds.23954
  35. Strouwen C, 2017, MOVEMENT DISORD, V32, P1201, DOI 10.1002/mds.27014
  36. Sturkenboom IHWM, 2014, LANCET NEUROL, V13, P557, DOI 10.1016/S1474-4422(14)70055-9
  37. Thomas A, 2004, J NEUROL NEUROSUR PS, V75, P141
  38. Tofani M, 2020, MOV DISORD CLIN PRAC, V7, P891, DOI 10.1002/mdc3.13089
  39. van der Kolk NM, 2019, LANCET NEUROL, V18, P998, DOI 10.1016/S1474-4422(19)30285-6
  40. Verschuur CVM, 2019, NEW ENGL J MED, V380, P315, DOI 10.1056/NEJMoa1809983
  41. WALKER JE, 1972, CLIN PHARMACOL THER, V13, P28
  42. WALKER JE, 1972, J CHRON DIS, V25, P149, DOI 10.1016/0021-9681(72)90171-3
  43. Watts RL, 2007, NEUROLOGY, V68, P272, DOI 10.1212/01.wnl.0000252355.79284.22
  44. Widnell KL, 2005, MOVEMENT DISORD, V20, pS30, DOI 10.1002/mds.20461
  45. Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4
  46. Wolf E, 2010, MOVEMENT DISORD, V25, P1357, DOI 10.1002/mds.23034
  47. Wong KS, 2003, J NEUROL SCI, V216, P81, DOI 10.1016/S0022-510X(03)00217-X
  48. Capato TTC, 2020, J PARKINSON DIS, V10, P333, DOI 10.3233/JPD-191752
  49. Castrioto A, 2011, ARCH NEUROL-CHICAGO, V68, P1550, DOI 10.1001/archneurol.2011.182
  50. Cattaneo C, 2016, J PARKINSON DIS, V6, P165, DOI 10.3233/JPD-150700
  51. Chang Y, 2017, ANN MED, V49, P421, DOI 10.1080/07853890.2017.1293285
  52. Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654
  53. Conradsson D, 2015, NEUROREHAB NEURAL RE, V29, P827, DOI 10.1177/1545968314567150
  54. Contin M, 1996, CLIN PHARMACOKINET, V30, P463, DOI 10.2165/00003088-199630060-00004
  55. Contin M, 2010, J NEUROL, V257, pS253, DOI 10.1007/s00415-010-5728-8
  56. Crosby N, 2003, Cochrane Database Syst Rev, pCD003468
  57. DeLong MR, 2014, JAMA NEUROL, V71, P1290, DOI 10.1001/jamaneurol.2014.1272
  58. Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281
  59. Durif F, 2004, NEUROLOGY, V62, P381, DOI 10.1212/01.WNL.0000110317.52453.6C
  60. Espay AJ, 2018, ANN NEUROL, V84, P797, DOI 10.1002/ana.25364
  61. Fahn S, 2004, NEW ENGL J MED, V351, P2498
  62. Ferreira JJ, 2013, EUR J NEUROL, V20, P5, DOI 10.1111/j.1468-1331.2012.03866.x
  63. Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083
  64. Fox SH, 2018, MOVEMENT DISORD, V33, P1248, DOI 10.1002/mds.27372
  65. Fox SH, 2013, DRUGS, V73, P1405, DOI 10.1007/s40265-013-0105-4
  66. Frazzitta G, 2009, MOVEMENT DISORD, V24, P1139, DOI 10.1002/mds.22491
  67. Freitas ME, 2017, SEMIN NEUROL, V37, P147, DOI 10.1055/s-0037-1602423
  68. Ghika J, 1997, CLIN NEUROPHARMACOL, V20, P130, DOI 10.1097/00002826-199704000-00004
  69. Ginis P, 2018, ANN PHYS REHABIL MED, V61, P407, DOI 10.1016/j.rehab.2017.08.002
  70. Gomide L, 2008, ARQ NEURO-PSIQUIAT, V66, P611, DOI 10.1590/S0004-282X2008000500001
  71. Gronseth GS., 2017, CLIN PRACTICE GUIDEL, V2017 ed
  72. Guttman M, 1997, NEUROLOGY, V49, P1060, DOI 10.1212/WNL.49.4.1060
  73. Hauser RA, 2014, MOVEMENT DISORD, V29, P1028, DOI 10.1002/mds.25877
  74. HELY MA, 1994, J NEUROL NEUROSUR PS, V57, P903, DOI 10.1136/jnnp.57.8.903
  75. HUTTON JT, 1984, CLIN NEUROPHARMACOL, V7, P135, DOI 10.1097/00002826-198406000-00003
  76. Hutton JT, 2001, MOVEMENT DISORD, V16, P459, DOI 10.1002/mds.1085
  77. Ives NJ, 2004, BMJ-BRIT MED J, V329, P593, DOI 10.1136/bmj.38184.606169.AE
  78. JABBARI B, 1989, MOVEMENT DISORD, V4, P202, DOI 10.1002/mds.870040302
  79. Jankovic J, 2007, CNS DRUGS, V21, P677, DOI 10.2165/00023210-200721080-00005
  80. Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3
  81. Katzenschlager R, 2003, COCHRANE DB SYST REV, V2002, DOI [10.1002/14651858.CD003735, DOI 10.1002/14651858.CD003735]
  82. Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244
  83. Koeglsperger T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00410
  84. Koller WC, 1999, NEUROLOGY, V53, P1012, DOI 10.1212/WNL.53.5.1012
  85. Korczyn AD, 1998, MOVEMENT DISORD, V13, P46, DOI 10.1002/mds.870130112
  86. Krack P, 2019, MOVEMENT DISORD, V34, P1795, DOI 10.1002/mds.27860
  87. Lee DJ, 2019, J NEUROSURG, V131, P333, DOI 10.3171/2019.4.JNS181761
  88. LeWitt PA, 2007, NEUROLOGY, V68, P1262, DOI 10.1212/01.wnl.0000259516.61938.bb
  89. LeWitt PA, 2013, J NEURAL TRANSM, V120, P1069, DOI 10.1007/s00702-012-0925-5
  90. Lhommee E, 2018, LANCET NEUROL, V17, P223, DOI 10.1016/S1474-4422(18)30035-8
  91. Li J, 2017, EUR NEUROL, V78, P143, DOI 10.1159/000479555
  92. Lieberman A, 1997, NEUROLOGY, V49, P162, DOI 10.1212/WNL.49.1.162
  93. Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa
  94. Macleod AD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004898.pub2, 10.1002/14651858.CD003234.pub2]
  95. Mak MKY, 2008, MOVEMENT DISORD, V23, P501, DOI 10.1002/mds.21509
  96. Manor Y, 2013, PARKINSONISM RELAT D, V19, P207, DOI 10.1016/j.parkreldis.2012.10.004
  97. Metman LV, 1998, NEUROLOGY, V50, P1323, DOI 10.1212/WNL.50.5.1323
  98. Mizuno Y, 2003, MOVEMENT DISORD, V18, P1149, DOI 10.1002/mds.10508
  99. Monticone M, 2015, MOVEMENT DISORD, V30, P1050, DOI 10.1002/mds.26256
  100. Munhoz RP, 2016, CAN J NEUROL SCI, V43, P462, DOI 10.1017/cjn.2016.35
  101. Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923
  102. Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0
  103. Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335
  104. Ortelli P, 2018, J PARKINSON DIS, V8, P113, DOI 10.3233/JPD-171247

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/IOT
Artigos e Materiais de Revistas Científicas - LIM/45
Artigos e Materiais de Revistas Científicas - LIM/62